CXCR2 and cancer: Endothelial cell-generated TNF-α then triggers CXCL1/2 expression by cancer cells, which subsequently recruits CD11b+Gr1+ myeloid-derived suppressor cells that express CXCR2 (the receptor for CXCL1/2).